MANGALAM DRUGS & ORGANICS LTD. - 532637 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication for notice of AGM07-09-2023
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication for notice of AGMMANGALAM DRUGS & ORGANICS LTD. - 532637 - AGM NOTICE AND ANNUAL REPORT FOR THE FINANCIAL YEAR ENDED MARCH 31 2023
AGM NOTICE AND ANNUAL REPORTMANGALAM DRUGS & ORGANICS LTD. - 532637 - AGM SCHEDULED TO BE HELD ON 29TH SEPTEMBER, 2023
We wish to inform that the 50th Annual general meeting of the company is scheduled to be held on Friday September 29 2023MANGALAM DRUGS & ORGANICS LTD. - 532637 - Reg. 34 (1) Annual Report.
Annual Report for the Financial year ended March 31 2023.MANGALAM DRUGS & ORGANICS LTD. - 532637 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of the un audited financial results for the quarter ended June 30 2023MANGALAM DRUGS & ORGANICS LTD. - 532637 - Financial Results For The Quarter Ended June 30 2023
Unaudited financial results for the quarter ended June 30 2023 along with the Limited review report on the same.MANGALAM DRUGS & ORGANICS LTD. - 532637 - Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday, August 10, 2023
Pursuant to Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations) we wish to inform that the Board of Directors of the Company at its meeting held today i.e., August 10, 2023 inter-alia transacted the following business: 1. Considered & approved the Un-Audited Financial Results for the quarter ended June 30, 2023 along with the Limited Review Report on the results pursuant to Regulation 33 of the Listing RegulationsMANGALAM DRUGS & ORGANICS LTD. - 532637 - Board Meeting Intimation for Mangalam Drugs And Organics Limited 'The Company'- Intimation Of Board Meeting To Be Held On Thursday, August 10, 2023
MANGALAM DRUGS & ORGANICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 ,inter alia, to consider and approve the Un-Audited Financial Results of the Company for the quarter ended June 30, 2023(Q1).MANGALAM DRUGS & ORGANICS LTD. - 532637 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance certificate under Reg 74(5) of SEBI DP Regulations for the quarter ended June 30 2023.MANGALAM DRUGS & ORGANICS LTD. - 532637 - Closure of Trading Window
CLOSURE OF TRADING WINDOW FOR DEALING IN SECURITIES OF THE COMPANY FOR DESIGNATED PERSONS FROM SATURDAY JULY 01 2023 TILL 48 HOURS AFTER THE DECLARATION OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTED ENDED JUNE 30 2023